期刊文献+

罗格列酮对内皮祖细胞增殖、黏附及迁移能力的影响 被引量:6

Effect of rosiglitazone on ability of proliferation, conglutination and transfere of endot-helial progenitor of cells in vitro
下载PDF
导出
摘要 目的:观察罗格列酮(rosiglitazone,Ros)对体外培养内皮祖细胞(endothelial progenitor cells,EPCs)增殖、黏附及迁移能力的影响。方法:以密度梯度离心法获取脐血单个核细胞,培养7d后收集贴壁细胞并分为正常对照组、单独Ros(1μmol/L、5μmol/L及10μmol/L)组、H2O2(500μmol/L)氧化应激模型组、Ros(1μmol/L、5μmol/L及10μmol/L)和H2O2共同干预组,培养24h。用流式细胞仪检测细胞表达CD34、CD133、VEGFR-2、VE-Cadherin并用荧光显微镜观察细胞吞噬DiI-ac-LDL和FITC-UEA-1来鉴定EPCs。分别用CCK-8、普通光学倒置显微镜、改良的Boyden小室检测EPCs的增殖、黏附和迁移能力。结果:与正常对照组相比,单独Ros干预组呈浓度依赖性促进脐血来源的EPCs增殖、黏附及迁移能力(均P<0.05),但是Ros5μmol/L和10μmol/L组间没有显著差异(P>0.05);与H2O2氧化应激损伤组相比,Ros能呈浓度依赖性改善H2O2对EPCs增殖、黏附及迁移功能的抑制(均P<0.05),Ros5μmol/L和10μmol/L干预保护组之间没有显著差异(均P>0.05)。结论:噻唑烷二酮(TZDs)类药物Ros除具有激动PPAR-γ受体降糖作用外,还具有抗氧化应激损伤作用。Ros能促进EPCs功能,改善H2O2致EPCs功能的氧化应激损伤。 Objective: To study the effect of rosiglitazone on the ability of proliferation, conglutination and transfere of endothelial progenitor cell in vitro. Methods: Total mononuclear cells were isolated from the umbilical cord blood with ficoll density gradient centrifugation, after the redblood cells were precipitated by hydroxyethyl starch, and cultured in vitro. Cells were cultured for 7 days, which expressed CD34/CD133/VEGFR-2/VE-Cadherin tested by flow cytometry and ability of intaking DIL-ac-LDL and FITC-UEA-1 tested under fluorescence microscope were identified as EPCs. EPCs were determined after treatment with rosiglitazone (1, 5, 10 mmol/L) alone and in the presence of H2O2 (500 umol/L) for 24 h. EPCs' functions were assayed with CCK-8, Boyden cabin, and adherent cells were counted under inverted microscope. Results: Compared to the control group, rosiglitazone groups, concentration dependence improved cells' function(sP〈0.05), there was no significant difference between rosiglitazone 5 mmol/L group and 10 mmol/L grou(pP〉0.05). In the same versus to the H2O2 group rosiglitazone groups concentration-dependent protected EPCs from oxidative stress(P〈0.05). Conclusion: Rosiglitazone has other effect of anti-oxidative stress beside euglycemic agent on EPCs. Rosiglitazone concentration-dependent promotes EPCs' functions and improves the injury of oxidative stress caused by H2O2.
出处 《温州医学院学报》 CAS 2008年第1期4-8,共5页 Journal of Wenzhou Medical College
基金 浙江省自然科学基金资助项目(M303648) 温州市科技局科研基金资助项目(Y2004A010)
关键词 罗格列酮 内皮祖细胞 过氧化氢 氧化应激 rosiglitazoneon,endothelial progenitor cells,hydrogen dioxide,oxidative stress
  • 相关文献

参考文献12

  • 1Imanishi T,Hano T,Nishio I.Angiotensin Ⅱ potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells[J].Hypertens Res,2004,27(2):101-108. 被引量:1
  • 2Imanishi T,Hano T,Sawamura T,et al.Oxidized low-density lipoprotein induces endothelial progenitor cell senescence,leading to cellular dysfunction[J].Clin Exp Pharmacol Physiol,2004,31(7):407-413. 被引量:1
  • 3Wang CH,Ciliberti N,Li SH,et al.Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage:a new paradigm in glitazone pleiotropy[J].Circulation,2004,109(11):1392-1400. 被引量:1
  • 4Onuts G,Rienstra H,de Boer JF,et al.Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats[J].Transplantion,2007,84(4):517-526. 被引量:1
  • 5Bolten CW,Payne MA,McDonald WG,et al.Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive rat[J].Diab Vasc Dis Res,2007,4(2):117-123. 被引量:1
  • 6张怀勤,胡盛寿,杨德业,张浩,周浩,黄晓燕,吴建波.脐血来源的人类内皮前体细胞培养的实验研究[J].中国循环杂志,2003,18(6):456-457. 被引量:16
  • 7郭永芳,赵莹,宋达琳,康维强.冠心病合并代谢综合征危险因素患者胰岛素抵抗与氧化应激的关系[J].医学检验与临床,2007,19(2):15-16. 被引量:4
  • 8林杰,张怀勤.内皮祖细胞治疗冠脉粥样硬化前景[J].中国全科医学,2007,10(17):1466-1469. 被引量:5
  • 9Rios-Vazquez R,Marzoa-Rivas R,Gil-Ortega I,et al.Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitus[J].Am J Cardiovasc Drugs,2006,6(4):231-242. 被引量:1
  • 10Meisner F,Walcher D,Gizard F,et al.Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients:data from a randomized placebo-controlled trial[J].Arterioscler Thromb Vasc Biol,2006,26(4):845-850. 被引量:1

二级参考文献3

共引文献22

同被引文献42

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部